Advanced Search

FOCUS, VOL. 9, No. 1

INFLUENTIAL PUBLICATIONS | December 01, 2011

Bibliography: for Addiction

FOCUS 2011;9:72-74.

Article

References

text A A A

Abstract

This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically and within years by first author. Articles from the bibliography that are reprinted in this issue are in bold type.

Figures in this Article

References

Abstract | References | Alcohol Use Disorders | Drugs of Abuse: Stimulants, Opioids, Nicotine, Prescription Medications

Greenfield SF, Back SE, Lawson K, Brady KT: Substance abuse in women. Psychiatr Clin North Am 2010; 33:339—355
[CrossRef] | [PubMed]

Ho MK, Goldman D, Heinz A, Kaprio J, Kreek MJ, Li MD, Munafò MR, Tyndale RF: Breaking barriers in the genomics and pharmacogenetics of drug addiction. Clin Pharmacol Ther 2010; 88:779—791
[CrossRef] | [PubMed]

Sellman D: The 10 most important things known about addiction. Addiction 2010; 105:6—13
[CrossRef] | [PubMed]

Swendsen J, Conway KP, Degenhardt L, Glantz M, Jin R, Merikangas KR, Sampson N, Kessler RC: Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction 2010; 105:1117—1128
[CrossRef] | [PubMed]

Tuchman E: Women and addiction: the importance of gender issues in substance abuse research. J Addict Dis 2010; 29:127—138. Available online at http://www.informaworld.com/smpp/title∼db=all∼content=g921472153

Kalivas PW: The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 2009; 10:561—572
[CrossRef] | [PubMed]

Carroll KM, Ball SA, Martino S, Nich C, Babuscio TA, Nuro KF, Gordon MA, Portnoy GA, Rounsaville BJ: Computer-assisted delivery of cognitive behavioral therapy for addiction. A randomized trial of CBT4CBT. Am J Psychiatry 2008; 165:881—888
[CrossRef] | [PubMed]

Dutra L, Stathopoulou G, Basden SL, Levro TM, Powers MB, Otto MW: A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008; 165:179—187
[CrossRef] | [PubMed]

McLellan AT, Skipper GS, Campbell M, DuPont RL: Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States. BMJ 2008; 337:a2038
[CrossRef] | [PubMed]

O'Brien CP: Evidence-based treatments of addiction. Phil Trans R Soc B 2008; 363:3277—3286
[CrossRef] | [PubMed]

Orford J: Asking the right questions in the right way: the need for a shift in research on psychological treatments for addiction. Addiction 2008; 103:875—885; discussion 886—892
[CrossRef] | [PubMed]

Wong CCY, Schumann G: Genetics of addictions: strategies for addressing heterogeneity and polygenicity of substance use disorders Phil Trans R Soc B 2008; 363:3213—3222
[CrossRef] | [PubMed]

Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J: Screening, brief intervention, and referral to treatment (SBIRT): toward a public health approach to the management of substance abuse. Substance Abuse 2007; 28:7—30
[CrossRef] | [PubMed]

Carroll KM, Rounsaville BJ: A vision of the next generation of behavioural therapies in the addictions. Addiction 2007; 102:850—862
[CrossRef] | [PubMed]

Green AI, Drake RE, Brunette MF, Noordsy DL: Schizophrenia and co-occurring substance use disorder. Am J Psychiatry 2007; 164:402—408
[CrossRef] | [PubMed]

Otto MW, O'Cleirigh CM, Pollack MH: Attending to emotional cues for drug abuse: bridging the gap between clinic and home behaviors. Sci Pract Perspect 2007; 3:48—56
[CrossRef] | [PubMed]

Saunders JB, Schuckit MA, Sirovatka PJ, Regier DA (eds): Diagnostic Issues in Substance Use Disorders: Refining the Research Agenda for DSM-V. Arlington, VA, American Psychiatric Association, 2007

Baler RD, Volkow ND: Drug addiction: the neurobiology of disrupted self-control. Trends Mol Med 2006; 12:559—566
[CrossRef] | [PubMed]

Room R: Taking account of cultural and societal influences on substance use diagnoses and criteria. Addiction 2006; 101:31—39

Schuckit MA: Comorbidity between substance use disorders and psychiatric conditions. Addiction 2006; 101:76—88
[CrossRef] | [PubMed]

Kalivas PW, Volkow ND: The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005; 162:1403—1413
[CrossRef] | [PubMed]

Alcohol Use Disorders

Abstract | References | Alcohol Use Disorders | Drugs of Abuse: Stimulants, Opioids, Nicotine, Prescription Medications

Schuckit MA, Smith TL: Onset and course of alcoholism over 25 years in middle class men. Drug Alcohol Depend 2011; 113:21—28
[CrossRef] | [PubMed]

Bierut LJ, Agrawal A, Bucholz KK, Doheny KF, Laurie C, Pugh E, Fisher S, Fox L, Howells W, Bertelsen S, Hinrichs AL, Almasy L, Breslau N, Culverhouse RC, Dick DM, Edenberg HJ, Foroud T, Grucza RA, Hatsukami D, Hesselbrock V, Johnson EO, Kramer J, Krueger RF, Kuperman S, Lynskey M, Mann K, Neuman RJ, Nöthen MM, Nurnberger JI Jr, Porjesz B, Ridinger M, Saccone NL, Saccone SF, Schuckit MA, Tischfield JA, Wang JC, Rietschel M, Goate AM, Rice JP, Environment Association Studies Consortium: A genome-wide association study of alcohol dependence. Proc Natl Acad Sci USA 2010; 107:5082—5087
[CrossRef] | [PubMed]

Johnson BA: Medication treatment of different types of alcoholism. Am J Psychiatry ; 2010: 167:630—639
[CrossRef] | [PubMed]

Pettinati HM, Oslin DW, Kampman KM, Dundon WD, Xie H, Gallis TL, Dackis CA, O'Brien CP: A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatry 2010; 167:668—675
[CrossRef] | [PubMed]

Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J: Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009; 373:2223—2233
[CrossRef] | [PubMed]

Adamson SJ, Sellman JD, Frampton CMA: Patient predictors of alcohol treatment outcome: a systematic review. J Subst Abuse Treat 2009; 36:75—86
[CrossRef] | [PubMed]

Schuckit MA: Alcohol-use disorders. Lancet 2009; 373:492—501
[CrossRef] | [PubMed]

Schuckit MA: An overview of genetic influences in alcoholism. J Subst Abuse Treat 2009; 36:S5—S14
[PubMed]

Anton RF, Oroszi G, O'Malley S, Couper D, Swift R, Pettinati H, Goldman D: An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence. Arch Gen Psychiatry 2008; 65:135—144
[CrossRef] | [PubMed]

Blomeyer D, Treutlein J, Esser G, Schmidt MH, Schumann G, Laucht M: Interaction between Crhr1 gene and stressful life events predicts adolescent heavy alcohol use. Biol Psychiatry 2008; 63:146—151
[CrossRef] | [PubMed]

Johnson BA: Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem Pharmacol 2008; 75:34—56
[CrossRef] | [PubMed]

Sommer WH, Rimondini R, Hansson AC, Hipskind PA, Gehlert DR, Barr CS, Heilig MA: Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala Crhr1 expression following a history of dependence. Biol Psychiatry 2008; 63:139—145
[CrossRef] | [PubMed]

National Institute of Alcohol Abuse and Alcoholism: Helping Patients Who Drink Too Much: A Clinician's Guide: NIH Publication 07-3769, Bethesda, MD, National Institutes of Health, 2007www.niaaa.nih.gov/guide

Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A: Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 2006; 295:2003—2017
[CrossRef] | [PubMed]

Khantzian EJ, Mack JE: How AA works and why it's important for clinicians to understand. J Subst Abuse Treat 1994; 11:77—92
[CrossRef] | [PubMed]

Edwards G, Gross M: Alcohol dependence: provisional description of a clinical syndrome. Br Med J 1976; 1:1058—1061
[CrossRef] | [PubMed]

Drugs of Abuse: Stimulants, Opioids, Nicotine, Prescription Medications

Abstract | References | Alcohol Use Disorders | Drugs of Abuse: Stimulants, Opioids, Nicotine, Prescription Medications

Castells X, Casas M, Pérez-Mañá C, Roncero C, Vidal X, Capellà D: Efficacy of psychostimulant drugs for cocaine dependence. Cochrane Database Syst Rev 2010; 2:CD007380
[PubMed]

Fenton MC, Keyes KM, Martins SS, Hasin DS: The role of a prescription in anxiety medication use, abuse, and dependence. Am J Psychiatry 2010; 167:1247—1253
[CrossRef] | [PubMed]

Hernandez SH, Nelson LS: Prescription drug abuse: insight into the epidemic. Clin Pharmacol Ther 2010; 88:307—317
[CrossRef] | [PubMed]

Maldonado JR: An approach to the patient with substance use and abuse. Med Clin North Am 2010; 94:1169—1205
[CrossRef] | [PubMed]

Manchikanti L, Fellows B, Ailinani H, Pampati V: Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 2010; 13:401—435
[PubMed]

Schuman-Olivier Z, Albanese M, Nelson SE, Roland L. Puopolo F, Klinker L, Shaffer HJ: Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers. J Subst Abuse Treat 2010; 39:41—50
[CrossRef] | [PubMed]

Sullivan LE, Moore BA, O'Connor PG, Barry DT, Chawarski MC, Schottenfeld RS, Fiellin DA: The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence. Am J Addict 2010; 19:53—58
[CrossRef] | [PubMed]

Volkow ND, Fowler JS, Wang GJ, Telang F, Logan J, Jayne M, Ma Y, Pradhan K, Wong C, Swanson JM: Cognitive control of drug craving inhibits brain reward regions in cocaine abusers. Neuroimage 2010; 49:2536—2543
[CrossRef] | [PubMed]

Back SE, Waldrop AE, Brady KT: Treatment challenges associated with comorbid substance use and posttraumatic stress disorder: clinicians' perspectives. Am J Addict 2009; 18:15—20
[CrossRef] | [PubMed]

Dwoskin LP, Smith AM, Wooters TE, Zhang Z, Crooks PA, Bardo MT: Nicotinic receptor-based therapeutics and candidates for smoking cessation. Biochem Pharmacol 2009; 78:732—743
[CrossRef] | [PubMed]

Hall W, Degenhardt L: Adverse health effects of non-medical cannabis use. Lancet 2009; 374:1383—1391
[CrossRef] | [PubMed]

Krasnova IN, Cadet JL: Methamphetamine toxicity and messengers of death. Brain Res Rev 2009; 60:379—407
[CrossRef] | [PubMed]

Martell BA, Orson FM, Poling J, Mitchell E, Rossen RD, Gardner T, Kosten TR: Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double blind, placebo-controlled efficacy trial. Arch Gen Psychiatry 2009; 66:1116—1123
[CrossRef] | [PubMed]

Parr JM, Kavanagh DJ, Cahill L, Mitchell G, McD Young R: Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Addiction 2009; 104:13—24

Vocci FJ, Montoya ID: Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence. Curr Opin Psychiatry 2009; 22:263—268
[CrossRef] | [PubMed]

Fiellin DA: Treatment of adolescent opioid dependence: no quick fix. JAMA 2008; 300:2057—2059
[CrossRef] | [PubMed]

Lee NK, Rawson RA: A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev 2008; 27:309—317
[CrossRef] | [PubMed]

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P: Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 2008; 8:287—313
[CrossRef] | [PubMed]

Trescot AM, Helm S, Hansen H, Benyamin R, Glaser SE, Adlaka R, Patel S, Manchikanti L: Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician 2008; 11(2 suppl):S5—S62
[PubMed]

Wu LT, Blazer DG: Illicit and nonmedical drug use among older adults: a review. Pain Physician 2008; 11(2 suppl):S63—S88
[PubMed]

Kleber HD, Weiss RD, Anton RF Jr, George TP, Greenfield SF, Kosten TR, O'Brien CP, Rounsaville BJ, Strain EC, Ziedonis DM, Hennessy G, Connery HS, McIntyre JS, Charles SC, Anzia DJ, Cook IA, Finnerty MT, Johnson BR, Nininger JE, Summergrad P, Woods SM, Yager J, Pyles R, Cross CD, Peele R, Shemo JP, Lurie L, Walker RD, Barnovitz MA, Gray SH, Saxena S, Tonnu T, Kunkle R, Albert AB, Fochtmann LJ, Hart C, Regier D; Work Group on Substance Use Disorders; American Psychiatric Association; Steering Committee on Practice Guidelines: Treatment of patients with substance use disorders, second edition. Am J Psychiatry 2007; 164(4 suppl):5—123

Knapp WP, Soares BG, Farrel M, Lima MS: Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database Syst Rev 2007; 3:CD003023
[PubMed]

Roll JM, Petry NM, Stitzer ML, Brecht ML, Peirce JM, McCann MJ, Blaine J, MacDonald M, DiMaria J, Lucero L, Kellogg S: Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry 2006; 163:1993—1999
[CrossRef] | [PubMed]

DiClemente CC, Prochaska JO, Fairhurst S, Velicer WF, Velasquez MM, Rossi JS: The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol 1991; 59:295—304
[CrossRef] | [PubMed]